Exercise Medicine for Cancer Cachexia : Targeted Exercise to Counteract Mechanisms and Treatment Side Effects
Mavropalias, G., Sim, M., Taaffe, D., Galvão, D. A., Spry, N., Kraemer, W., Häkkinen, K., & Newton, R. (2022). Exercise Medicine for Cancer Cachexia : Targeted Exercise to Counteract Mechanisms and Treatment Side Effects. Journal of Cancer Research and Clinical Oncology, 148(6), 1389-1406. https://doi.org/10.1007/s00432-022-03927-0
Julkaistu sarjassa
Journal of Cancer Research and Clinical OncologyTekijät
Päivämäärä
2022Tekijänoikeudet
© The Author(s) 2022
Purpose -- Cancer-induced muscle wasting (i.e., cancer cachexia, CC) is a common and devastating syndrome that results in the death of more than 1 in 5 patients. Although primarily a result of elevated inflammation, there are multiple mechanisms that complement and amplify one another. Research on the use of exercise to manage CC is still limited, while exercise for CC management has been recently discouraged. Moreover, there is a lack of understanding that exercise is not a single medicine, but mode, type, dosage, and timing (exercise prescription) have distinct health outcomes. The purpose of this review was to examine the effects of these modes and subtypes to identify the most optimal form and dosage of exercise therapy specific to each underlying mechanism of CC. Methods -- The relevant literatures from MEDLINE and Scopus databases were examined. Results -- Exercise can counteract the most prominent mechanisms and signs of CC including muscle wasting, increased protein turnover, systemic inflammation, reduced appetite and anorexia, increased energy expenditure and fat wasting, insulin resistance, metabolic dysregulation, gut dysbiosis, hypogonadism, impaired oxidative capacity, mitochondrial dysfunction, and cancer treatments side-effects. There are different modes of exercise, and each mode has different sub-types that induce vastly diverse changes when performed over multiple sessions. Choosing suboptimal exercise modes, types, or dosages can be counterproductive and could further contribute to the mechanisms of CC without impacting muscle growth. Conclusion -- Available evidence shows that patients with CC can safely undertake higher-intensity resistance exercise programs, and benefit from increases in body mass and muscle mass.
...
Julkaisija
Springer Science and Business Media LLCISSN Hae Julkaisufoorumista
0171-5216Asiasanat
Alkuperäislähde
http://dx.doi.org/10.1007/s00432-022-03927-0Julkaisu tutkimustietojärjestelmässä
https://converis.jyu.fi/converis/portal/detail/Publication/104042869
Metadata
Näytä kaikki kuvailutiedotKokoelmat
- Liikuntatieteiden tiedekunta [3123]
Lisätietoja rahoituksesta
Open Access funding enabled and organized by CAUL and its Member Institutions. No funding was received for this work. The salary of MS is supported by a Royal Perth Hospital Career Advancement Fellowship.Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Molecular and physiological effects of muscle wasting and its treatment by blocking myostatin and activins
Nissinen, Tuuli (Jyväskylän yliopisto, 2020)Muscle wasting, occurring e.g. in cancer, is associated with poor prognosis, and cancer treatments may even exacerbate the wasting. The prevention of muscle wasting has improved survival in preclinical cancer models, but ... -
Activin-A, myostatin and interleukin-6 in cancer associated cachexia
Härkönen, Jouni (2017)Cachexia is a muscle wasting condition associated with multiple different chronic illnesses, such as cancer, diabetes and AIDS. In cancer, approximately 80% of patients with advanced disease have symptoms of muscle wasting, ... -
NAD+ repletion with niacin counteracts cancer cachexia
Beltrà, Marc; Pöllänen, Noora; Fornelli, Claudia; Tonttila, Kialiina; Hsu, Myriam Y.; Zampieri, Sandra; Moletta, Lucia; Corrà, Samantha; Porporato, Paolo E.; Kivelä, Riikka; Viscomi, Carlo; Sandri, Marco; Hulmi, Juha J.; Sartori, Roberta; Pirinen, Eija; Penna, Fabio (Nature Publishing Group, 2023)Cachexia is a debilitating wasting syndrome and highly prevalent comorbidity in cancer patients. It manifests especially with energy and mitochondrial metabolism aberrations that promote tissue wasting. We recently identified ... -
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
Hulmi, Juha J.; Nissinen, Tuuli A.; Penna, Fabio; Bonetto, Andrea (MDPI, 2021)Muscle wasting, i.e., cachexia, frequently occurs in cancer and associates with poor prognosis and increased morbidity and mortality. Anticancer treatments have also been shown to contribute to sustainment or exacerbation ... -
Supervised Physical Training Enhances Muscle Strength but Not Muscle Mass in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy : A Systematic Review and Meta-Analysis
Chen, Ziyuan; Zhang, Yuan; Lu, Chunyan; Zeng, Hao; Schumann, Moritz; Cheng, Sulin (Frontiers Media, 2019)Introduction: Androgen deprivation therapy (ADT) is considered the basic treatment for advanced prostate cancer, but it is highly associated with detrimental changes in muscle mass and muscle strength. The aim of this ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.